Duopharma Biotech Berhad (KLSE:DPHARMA)
1.260
0.00 (0.00%)
At close: Oct 27, 2025
Duopharma Biotech Berhad Revenue
Duopharma Biotech Berhad had revenue of 221.78M MYR in the quarter ending June 30, 2025, with 1.58% growth. This brings the company's revenue in the last twelve months to 886.92M, up 18.57% year-over-year. In the year 2024, Duopharma Biotech Berhad had annual revenue of 813.70M with 15.46% growth.
Revenue (ttm)
886.92M
Revenue Growth
+18.57%
P/S Ratio
1.37
Revenue / Employee
453.21K
Employees
1,957
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 813.70M | 108.97M | 15.46% |
| Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
| Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
| Dec 31, 2021 | 639.18M | 69.27M | 12.16% |
| Dec 31, 2020 | 569.90M | -6.56M | -1.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tenaga Nasional Berhad | 64.76B |
| Malayan Banking Berhad | 28.41B |
| IHH Healthcare Berhad | 24.93B |
| CIMB Group Holdings Berhad | 20.75B |
| SD Guthrie Berhad | 20.51B |
| Press Metal Aluminium Holdings Berhad | 15.42B |
| Public Bank Berhad | 14.50B |
| Celcomdigi Berhad | 12.87B |